New method uses bacteria-enhanced graphene oxide nanoparticles for cancer photothermo-chemo-immunotherapy
Modern cancer treatments have evolved beyond traditional chemotherapy to include targeted approaches such as immunotherapy, radiation therapy, and photothermal therapy. Graphene oxide (GO) has emerged as a promising material for both drug delivery and thermal-based tumor destruction. However, its clinical application remains limited due to challenges in dispersibility and large-scale production.
To overcome these limitations, Professor Eijiro Miyako and his research team from the Japan Advanced Institute of Science and Technology (JAIST) have developed a novel GO nanocomposite enhanced with bacterial components. The study highlights how bacterial properties improve GO's effectiveness in cancer therapy. Certain bacteria naturally stimulate immune responses and enhance dispersibility of GO due to their amphiphilic cellular components.